| Sex (n, %). |
Male 19 (65.5%). |
| Age in years (median, IQR). |
60 (52-71). |
| Race (n, %) |
Caucasian 19 (65.5%)
ATSI 2 (6.9 %)
Pacific Islander 6 (20.7%)
Asian 2 (6.9 %) |
| Aetiology of renal failure (n, %) |
DM 16 (55.2%)
GN 6 (20.6%)
Other 7 (24.1%) |
| Dialysis vintage in months (mean, SD) |
66 (59). |
| Dialysis Access (n, %) |
Fistula: 27 (93.1%)
Graft: 2 (6.9%) |
| Starting Phosphate in mmol/L (mean, SD) |
1.89 (0.42). |
| Starting Calcium in mmol/L (mean, SD) |
2.32 (0.16). |
| Starting PTH in nmol/L (median, IQR) |
24 (11-82). |
| Phosphate binder pill burden: median number of pills per day (IQR). |
Calcium based: 3 (2-6).
Non-calcium based: 6 (3-9). |
| Taking Lanthanum (n, %) |
8 (27.6%). |
| Taking Sevelamer (n, %) |
14 (48.3%). |
| Taking Cincacalcet (n, %) |
15 (51.7%). |
| Taking Calcitriol (n, %) |
21 (72.4%). |
ATSI: Aboriginal/Torres strait islander; Pacific Islander=Maori,
Samoan, Tongan, DM: Diabetic nephropathy; GN:
Glomerulonephritis. |
